A phase II trial in patients with myelofibrosis primary post-ET or post PV-MF treated with the selective JAK2 inhibitor Pacritinib before reduced-intensity conditioning allogeneic stem cell transplantation
Study of Therapeutic Monitoring of CellCept Mycophenolate Mofetil After Kidney Transplantation